Nivolumab switch maintenance therapy after tyrosine kinase inhibitor induction in metastatic renal cell carcinoma: a randomized clinical trial by the interdisciplinary working group on renal tumors of the German cancer society (NIVOSWITCH; AIO-NZK-0116ass) - Grünwald, Viktor; Ivanyi, Philipp; Zschäbitz, Stefanie; Wirth, Manfred; Staib, Peter; Schostak, Martin; Dargatz, Philip; Müller, Lothar; Metz, Michael; Bergmann, Lothar; Steiner, Thomas; Welslau, Martin; et al. (European urology, 2023)
Gesehen am 02.02.2024